PureTech Health (OTCMKTS:PTCHF – Get Free Report) will likely be releasing its results before the market opens on Wednesday, April 29th. Analysts expect PureTech Health to post earnings of ($0.1940) per share and revenue of $1.90 million for the quarter.
PureTech Health Stock Performance
Shares of OTCMKTS:PTCHF opened at $1.76 on Tuesday. PureTech Health has a one year low of $1.49 and a one year high of $1.90. The company has a 50 day moving average of $1.64 and a 200-day moving average of $1.68.
PureTech Health Company Profile
PureTech Health PLC (“PureTech”) is a clinical-stage biopharmaceutical company focused on the development of innovative medicines to address serious diseases with high unmet medical need. Founded in 2005 by Daphne Zohar and headquartered in Boston, Massachusetts with operations in both North America and Europe, PureTech applies its proprietary platforms to advance therapeutic candidates across immunology, neuroscience and lymphatic-focused indications.
The company leverages three core technology platforms—immune tolerance, gut-targeted delivery and lymphatic transport—to develop novel molecules designed for enhanced specificity and durability of effect.
Featured Stories
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
